These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11579267)

  • 1. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery].
    Boix V; Murcia JM; Merino E; Portilla J
    Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
    Razavi B; Lund B; Allen BL; Schlesinger L
    Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
    Held M; Goebel FD
    Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444
    [No Abstract]   [Full Text] [Related]  

  • 12. Why does Pneumocystis carinii pneumonia still occur?
    Huang L; Hecht FM
    AIDS; 2000 Nov; 14(16):2611-2. PubMed ID: 11101076
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus.
    Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
    Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
    Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprophylaxis for Pneumocystis carinii pneumonia.
    Colebunders R; Denolf D; Verdonck K
    Pediatr Infect Dis J; 1999 Jul; 18(7):662. PubMed ID: 10440453
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.
    Degen O; ven Lunzen J; Horstkotte MA; Sobottka I; Stellbrink HJ
    AIDS; 2002 Jul; 16(10):1433-4. PubMed ID: 12131226
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-edged sword.
    Baxi S; Platts-Mills J; Dhruva S; Huang L; Hanks D; Dhaliwal G
    J Hosp Med; 2013 Jan; 8(1):47-51. PubMed ID: 23293015
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy.
    Crothers K; Huang L
    HIV Med; 2003 Oct; 4(4):346-9. PubMed ID: 14525547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.